CXCL10 and infection: It should be noted that DAA therapy has been extremely effective in inhibiting HCV replication, with a consequent reduction in IP-10 levels, in both HCV mono-infected and HCV/HIV co-infected, thus confirming it has an effective prognostic biomarker for the resolution of infection [26].